Document Detail


Multiple point action mechanism of valproic acid-teratogenicity alleviated by folic acid, vitamin C, and N-acetylcysteine in chicken embryo model.
MedLine Citation:
PMID:  22051200     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The teratogenicity of antiepilepsy drug valproic acid (VPA) mostly is found in genetic and somatic levels, causing teratogenesis involving neurotubular defects (NTDs), anencephaly, lumbosacral meningomyelocele, and leg dysfunction due to spina bifida aperta. A diversity of nutraceutics have been tried to alleviate the risk of VPA-teratogenicity. The effect was varying. In order to promote the preventive prescription, to find out its action mechanism can be rather crucial. We used chicken embryo model to try the effect of folic acid (FA), ascorbic acid (AA), and N-acetyl cysteine (NAC). VPA at 30mM showed the higher malformation rate (66.7%) with the least mortality (22.2%). Pathological findings indicated that the cervical muscle was more susceptible to VPA injury than the ankle muscle. VPA downregulated levels of superoxide dismutase (SOD), glutathione (GSH), histone deacetylase (HDAC) and folate, and upregulated H(2)O(2) and homocysteine. FA, AA, and NAC significantly upregulated SOD, but only AA alone activated GSH. AA and NAC downregulated H(2)O(2), while FA was totally ineffective. All three nutraceutics comparably rescued HDAC with simultaneously suppressed homocysteine accumulation and folate re-elevation, although less effectively by NAC. Based on these data, we conclude VPA possesses "Multiple Point Action Mechanism". In addition to affecting the cited transcription and translation levels, we hypothesize that VPA competitively antagonize the glutamic acid to couple with pteroic acid in biosynthesis of dihydrofolic acid (DHFA). H(2)O(2) directly destroyed the NADPH reducing system at dihydrofolate reductase (DHFR) and methylene tetrahydrofolate reductase (MTHFR) levels, while completely restored by AA, an implication in preservation of intact apoenzymes. In addition, the GSH-GSSG system is sandwiched between the reducing systems NADPH/NADP and DHA-AA, its net balance is highly dependent on in situ in vivo Redox state, hence folic acid transformation is varying. To rescue the VPA-induced teratogenicity, simultaneous multiple prescriptions are suggested.
Authors:
Chiu-Lan Hsieh; Hui-Er Wang; Wan-Jane Tsai; Chiung-Chi Peng; Robert Y Peng
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-10-25
Journal Detail:
Title:  Toxicology     Volume:  291     ISSN:  1879-3185     ISO Abbreviation:  Toxicology     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2011-12-23     Completed Date:  2012-02-06     Revised Date:  2012-03-22    
Medline Journal Info:
Nlm Unique ID:  0361055     Medline TA:  Toxicology     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  32-42     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Graduate Institute of Biotechnology, Changhua University of Education, Jin-De Campus, 1 Jin-De Rd., Changhua 50007, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetylcysteine / blood,  pharmacology*
Animals
Anticonvulsants / antagonists & inhibitors*,  toxicity*
Antioxidants / pharmacology*
Ascorbic Acid / blood,  pharmacology*
Chick Embryo
Chromatography, High Pressure Liquid
Folic Acid / blood,  pharmacology*
Foot Deformities / chemically induced
Glutathione / metabolism
Hindlimb / abnormalities
Histone Deacetylases / metabolism
Homocysteine / metabolism
Hydrogen Peroxide / metabolism
Joints / abnormalities,  pathology
Muscle, Skeletal / abnormalities,  pathology
Neovascularization, Physiologic / drug effects
Superoxide Dismutase / metabolism
Teratogens*
Tissue Embedding
Valproic Acid / antagonists & inhibitors*,  toxicity*
Vitamins / blood,  pharmacology*
Chemical
Reg. No./Substance:
0/Anticonvulsants; 0/Antioxidants; 0/Teratogens; 0/Vitamins; 454-28-4/Homocysteine; 50-81-7/Ascorbic Acid; 59-30-3/Folic Acid; 616-91-1/Acetylcysteine; 70-18-8/Glutathione; 7722-84-1/Hydrogen Peroxide; 99-66-1/Valproic Acid; EC 1.15.1.1/Superoxide Dismutase; EC 3.5.1.98/Histone Deacetylases
Comments/Corrections
Comment In:
Toxicology. 2012 Mar 11;293(1-3):132-3   [PMID:  22248911 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Alleviation of lung injury by glycyrrhizic acid in benzo(a)pyrene exposed rats: Probable role of sol...
Next Document:  The lived experience of a foot burn injury from the perspective of seven Jordanians with diabetes: a...